Capoten in kidney disease
Executive Summary
400-patient, 24-center study funded by Squibb Institute for Medical Research and National Institute of Diabetes and Digestive and Kidney Diseases is under way. Previous research suggests that inhibition of angiotensin converting enzyme lowers blood pressure within the kidney's filtering system, preventing injury to the small blood vessels. Study is expected to last four years.